<< مقالات لاتين >>
<< بر اساس عنوان >>
1
Target selection for alignment of chromatographic signals obtained using monochannel detectors
2
Target selection in designingpasteurization processes for shelf-stable high-acid fruit products
3
Target setting for the departments in an aircraft repairable item system
4
Target setting in additive models with preferences and interval data
5
Target setting in the general combined-oriented CCR model using an interactive MOLP method
6
Target setting in the process of merging and restructuring of decision-making units using multiple objective linear programming
7
Target setting: A generalized concept of centralized resource allocation
8
Target setting: An application to a bank branch network
9
Target set-up for measurements with the use of a Si-ball detector
10
Target set-up for measurements with the use of a Si-ball detector
11
Target shareholdersʹ returns: The effect of diversity in accounting standards and tax treatments in cross-border acquisitions
12
Target Site Insensitivity Detection in Deltamethrin Resistant Culex pipiens Complex in Iran
13
Target site mutation and reduced translocation are present in a glyphosate-resistant Lolium multiflorum Lam. biotype from Spain
14
Target size and optimal life history when individual growth and energy budget are stochastic
15
Target space duality for (0,2) compactifications Original Research Article
16
Target space duality I: general theory Original Research Article
17
Target space duality II: applications Original Research Article
18
Target space duality in orbifolds with continuous and discrete Wilson lines Original Research Article
19
Target space pseudoduality between dual symmetric spaces Original Research Article
20
Target Specificity Analysis of the Abl Kinase using Peptide Microarray Data
21
Target stability and beam-induced background studies at the LUNA underground facility Original Research Article
22
Target strength effect on penetration by shaped charge jets
23
Target Strength Measurement of Myctophid (Benthosema pterotum) in the Oman Sea
24
Target structure and in-beam electron spectra
25
Target Structure-Based Discovery of Small Molecules that Block Human p53 and CREB Binding Protein Association Original Research Article
26
Target studies for the neutrino factory at the Rutherford Appleton laboratory
27
Target studies for the neutrino factory at the Rutherford Appleton laboratory
28
Target syntheses of saturated Keggin polyoxometalate-based extended solids
29
Target synthesis of a new bicapped keggin polyoxometalate derivative: [Co(phen)3]2[SiMoVI 8MoV 4VIV 2O42]$H2O
30
Target system neutronics study for NXGENS
31
Target system neutronics study for NXGENS
32
Target system of IFMIF/EVEDA in Japanese activities
33
Target Systems Overview for the Spallation Neutron Source
34
Target testing procedure for determining chemical kinetics from spectroscopic data with absorption shifts and baseline drift
35
Target thickness optimization design of a spallation neutron source target cooling system
36
Target tracking and boundary node selection algorithms of wireless sensor networks for internet services
37
TARGET TRACKING AND RECEIVER PLACEMENT IN MIMO DVB-T BASED PCL
38
Target Tracking Based on Virtual Grid in Wireless Sensor Networks
39
Target tracking by matching a shape represented by a tree of sigmoid functions
40
Target Tracking in MIMO Radar Systems Using Velocity Vector
41
Target Tracking Techniques for Wireless Sensor Networks
42
Target tracking using Monte Carlo simulation Original Research Article
43
Target tracking with distributed sensors: The focus of attention problem
44
Target tracking with incomplete detection
45
TARGET TRACKING WITH LINE-OF-SIGHT IDENTIFICATION IN SENSOR NETWORKS UNDER UNKNOWN MEASUREMENT NOISES
46
Target Tracking with Unknown Maneuvers Using Adaptive Parameter Estimation in Wireless Sensor Networks
47
Target transform fitting in a voltammetric study of metal complexation Original Research Article
48
Target treatment of female urinary dysfunction
49
Target treatment of female urinary dysfunction
50
Target velocity effects on manual interception kinematics
51
Target Vessel Detection and Coronary Anastomosis Assessment by Intraoperative 12-MHz Ultrasound
52
Target vessel revascularization without cardiopulmonary bypass in elderly high-risk patients
53
Target wave-packet control and its detection using time-resolved photoelectron spectroscopy
54
Target zone credibility and economic fundamentals
55
Target zone dynamics where the fundamental follows a SDE with periodic forcing
56
Target zone models with stochastic realignments: an econometric evaluation
57
Target zones and alternative proposals for G3 policy coordination: An empirical evaluation using GEM
58
Target zones and conditional volatility: The role of realignments
59
Target zones and exchange rates:: An empirical investigation
60
Target zones and small realignments
61
Target zones and small realignments
62
Target zones for exchange rates and policy changes
63
Target zones in theory and history: Credibility, efficiency, and policy autonomy
64
Target zones in theory and history: Credibility, efficiency, and policy autonomy$
65
Target zones, reserve crises, and inverted S-curves
66
Target/Blanket Design for the Accelerator Production of Tritium Plant
67
TARGET: A multi-channel digitizer chip for very-high-energy gamma-ray telescopes
68
Target-acquisition performance in undersampled infrared imagers: static imagery to motion video
69
Target-adaptive polarimetric synthetic aperture radar target discrimination using maximum average correlation height filters
70
Target-aimed versus wishful-thinking in designing efficient GHG reduction strategies for a metropolitan city: Taipei
71
Target-Attainment Rates of Low-Density Lipoprotein Cholesterol Using Lipid-Lowering Drugs One Year After Acute Myocardial Infarction in Sweden
72
Target-based discovery of novel herbicides
73
Target-controlled administration of inhaled anaesthetics
74
TARGET-CONTROLLED INFUSION ANESTHESIA WITH PROPOFOL AND REMIFENTANIL COMPARED WITH MANUALLY CONTROLLED INFUSION ANESTHESIA IN MASTOIDECTOMY SURGERIES
75
Target-controlled infusion of remifentanil with propofol or desflurane under bispectral index guidance: quality of anesthesia and recovery profile
76
Target-Directed Mixture Dynamic Models for Spontaneous Speech Recognition
77
Target-directed visual attention is a prerequisite for action-specific perception
78
Target-driven merging of taxonomies with Atom
79
Targeted (and chemotherapeutic) agents as maintenance treatment in patients with metastatic non-small-cell lung cancer: Current status and future challenges
80
Targeted ablation of gonadotrophs in transgenic mice affects embryonic development of lactotrophs
81
Targeted ablation of SOD1 promotes vascular remodeling induced by periadventitial injury
82
Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer
83
Targeted action on HIV and tuberculosis needed to reach drug users
84
Targeted Activation Tagging of the Arabidopsis NBS-LRR gene, ADR1, Conveys Resistance to Virulent Pathogens.
85
Targeted agents in AML: much more to do
86
Targeted agents in non-small cell lung cancer (NSCLC): Clinical developments and rationale for the combination with thoracic radiotherapy
87
Targeted agents in the third-/fourth-line treatment of patients with advanced (stage III/IV) non-small cell lung cancer (NSCLC)
88
Targeted agents: how can we improve the outcome in biliary tract cancer?
89
Targeted allylation and propargylation of galactose-containing polysaccharides in water
90
Targeted analysis of bioactive phenolic compounds and antioxidant activity of Macedonian red wines
91
Targeted analysis of polyphenol metabolism during development of hop (Humulus lupulus L.) cones following treatment with prohexadione-calcium
92
Targeted analysis with benchtop quadrupole–orbitrap hybrid mass spectrometer: Application to determination of synthetic hormones in animal urine Original Research Article
93
Targeted and intracellular delivery of paclitaxel using multi-functional polymeric micelles
94
Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression
95
Targeted and proximity-dependent promiscuous protein biotinylation by a mutant Escherichia coli biotin protein ligase
96
Targeted and ultrasound-triggered drug delivery using liposomes co-modified with cancer cell-targeting aptamers and a thermosensitive polymer
97
Targeted and ultrasound-triggered drug delivery using liposomes co-modified with cancer cell-targeting aptamers and a thermosensitive polymer
98
Targeted annotation of immunoglobulin light chain (IgL) genes in zebrafish from BAC clones reveals kappa-like recombining/deleting elements within IgL constant regions
99
Targeted Anticancer Therapies: Mouse Models Help Uncover the Mechanisms of Tumor Escape
100
Targeted Anticancer Therapies: Mouse Models Help Uncover the Mechanisms of Tumor Escape
101
Targeted Antipeptide Antibodies to Cytochrome P450 2C18 Based on Epitope Mapping of an Inhibitory Monoclonal Antibody to P450 2C51
102
Targeted binding of a platinum(II)–methionine complex to the disulfide linkage of a nonapeptide oxytocin
103
Targeted binding of PLA microparticles with lipid-PEG-tethered ligands
104
Targeted biopharmaceuticals for cancer treatment
105
Targeted bone remodeling involves BMU steering as well as activation
106
Targeted brain hypothermia induced by an interstitial cooling device in the rat neck: Experimental study and model validation
107
Targeted breast cancer screening in women younger than 40: results from a statewide program
108
Targeted Cancer Diagnostic and Therapeutic Agents: Delivery by Carriers or Conjugation
109
Targeted Cancer Therapy: A Hopeful Cure for Future
110
Targeted cardiac expression of soluble Fas prevents the development of heart failure in mice with cardiac-specific expression of MCP-1
111
Targeted Care in Comatose Patients with Head Injury: A Qualitative Content Analysis
112
Targeted cellular adhesion at biomaterial interfaces
113
Targeted Chemical-Genetic Regulation of Protein Stability In Vivo Original Research Article
114
Targeted chemotherapy in mice with peritoneally disseminated gastric cancer using monoclonal antibody–drug conjugate
115
Targeted chemotherapy with cytotoxic bombesin analogue AN-215 can overcome chemoresistance in experimental renal cell carcinomas: Keller G, Schally AV, Nagy A, Halmos G, Baker B, Engel JB, Endocrine, Polypeptide, and Cancer Institute, Veterans Affairs Med
116
Targeted Co-Delivery of Docetaxel and cMET siRNA for Treatment of Mucin1 Overexpressing Breast Cancer Cells
117
Targeted computational probabilistic corroboration of experimental knee wear simulator: The importance of accounting for variability
118
Targeted Correction of the Point Mutations of β-Thalassemia and Targeted Mutagenesis of the Nucleotide Associated with HPFH by RNA/DNA Oligonucleotides: Potential for β-Thalassemia Gene Therapy
119
Targeted cytotoxic analog of luteinizing hormone–releasing hormone AN-207 inhibits growth of OV-1063 human epithelial ovarian cancers in nude mice, ,
120
Targeted cytotoxic somatostatin analog AN-162 inhibits growth of human colon carcinomas and increases sensitivity of doxorubicin resistant murine leukemia cells
121
Targeted damage effects of high intensity focused ultrasound (HIFU) on liver tissues of Guizhou province miniswine
122
Targeted damage effects of high intensity focused ultrasound (HIFU) on liver tissues of Guizhou province miniswine
123
Targeted Deletion of AIF Decreases Mitochondrial Oxidative Phosphorylation and Protects from Obesity and Diabetes
124
Targeted deletion of caspase-1 reduces early mortality and left ventricular dilatation following myocardial infarction
125
Targeted Deletion of Los1 Homologue Affects the Production of a Recombinant Model Protein in Pichia pastoris
126
Targeted Deletion of the A3Adenosine Receptor Confers Resistance to Myocardial Ischemic Injury and does not Prevent Early Preconditioning
127
Targeted Deletion of the Calcineurin Inhibitor DSCR1 Suppresses Tumor Growth
128
Targeted Deletion Reveals Essential and Overlapping Functions of the miR-17∼92 Family of miRNA Clusters
129
Targeted Delivery of 5-fluorouracil with Monoclonal Antibody Modified Bovine Serum Albumin Nanoparticles
130
Targeted Delivery of Anti-CTLA-4 Antibody Downregulates T Cell Function in Vitro and in Vivo
131
Targeted delivery of doxorubicin and therapeutic FOXM1 aptamer to tumor cells using gold nanoparticles modified with AS1411 and ATP aptamers
132
Targeted delivery of doxorubicin into tumor cells via MMP-sensitive PEG hydrogel-coated magnetic iron oxide nanoparticles (MIONPs)
133
Targeted delivery of EV peptide to tumor cell cytoplasm using lipid coated calcium carbonate nanoparticles
134
Targeted delivery of galbanic acid to colon cancer cells by PLGA nanoparticles incorporated into human mesenchymal stem cells
135
Targeted delivery of heparin and LMWH using a fibrin antibody prevents restenosis
136
Targeted delivery of low molecular drugs using chitosan and its derivatives
137
Targeted delivery of mannan-coated superparamagnetic iron oxide nanoparticles to antigen-presenting cells for magnetic resonance-based diagnosis of metastatic lymph nodes in vivo
138
Targeted delivery of nanoparticles for the treatment of lung diseases
139
Targeted delivery of paclitaxel using folate-conjugated heparin-poly(β-benzyl-l-aspartate) self-assembled nanoparticles
140
Targeted delivery of paclitaxel using folate-decorated poly(lactide)–vitamin E TPGS nanoparticles
141
Targeted Delivery of Pennyroyal via Methotrexate Functionalized PEGylated Nanostructured Lipid Carriers into Breast Cancer Cells; A Multiple Pathways Apoptosis Activator
142
Targeted delivery of the ErbB2/HER2 tumor antigen to professional APCs results in effective antitumor immunity: Rohrbach F, Weth R, Kursar M, Sloots A, Mittrucker HW, Wels WS, Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Frankfurt am Main, G
143
Targeted Delivery of Therapeutic Agents by Smart Nanocarrier for Treatment of Parkinson’s Disease: A Novel Brain Targeting Approach
144
Targeted delivery of therapeutics to bone and connective tissues
145
Targeted delivery of thrombolytic enzymes
146
Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment
147
Targeted delivery system for juxtacrine signaling growth factor based on rhBMP-2-mediated carrier-protein conjugation
148
Targeted delivery to the nucleus
149
Targeted delivery using inorganic nanosystem
150
Targeted deposition of a conducting polymer based on bipolar electrochemistry
151
Targeted deposition of a conducting polymer based on bipolar electrochemistry
152
Targeted deposition of Au aerosol nanoparticles on vertical nanowires for the creation of nanotrees
153
Targeted destruction of murine macrophage cells with bioconjugated gold nanorods
154
Targeted detection of the cancer cells using the anti-CD24 bio modified PEGylated gold nanoparticles: the application of CD24 as a vital cancer biomarker
155
Targeted disease prophylaxis in European fish farming (TargetFish)
156
Targeted Disruption of Heparan Sulfate Interaction with Hepatocyte and Vascular Endothelial Growth Factors Blocks Normal and Oncogenic Signaling
157
Targeted disruption of PPARγ in bone marrow stromal cells reveals its role in aging-induced bone loss
158
Targeted Disruption of the CCR5 Gene in Human Hematopoietic Stem Cells Stimulated by Peptide Nucleic Acids Original Research Article
159
Targeted disruption of the galectin-3 gene results in decreased susceptibility to multiple low dose streptozotocin-induced diabetes in mice
160
Targeted disruption of the glutaredoxin 1 gene does not sensitize adult mice to tissue injury induced by ischemia/reperfusion and hyperoxia
161
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
162
Targeted disruption of β1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction
163
Targeted doxorubicin delivery by chitosan-galactosylated modified polymer microbubbles to hepatocarcinoma cells
164
Targeted drug conjugates: principles and progress
165
Targeted drug delivery by thermally responsive polymers
166
Targeted drug delivery for musculoskeletal diseases
167
Targeted Drug Delivery in Lipid-like Nanocages and Extracellular Vesicles
168
Targeted drug delivery using silica xerogel systems to treat diseases due to intracellular pathogens
169
Targeted drug delivery via the folate receptor
170
Targeted drug delivery via the folate receptor
171
Targeted drug delivery with dendrimers: Comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex
172
Targeted drugs for metastatic renal cell carcinoma
173
Targeted drugs take centre stage at US cancer meeting
174
Targeted eicosanoids lipidomics of exhaled breath condensate in healthy subjects
175
Targeted energy transfer between a Rotor and a Morse oscillator: A model for selective chemical dissociation
176
Targeted energy transfer by Fermi resonance
177
Targeted energy transfer in systems with non-polynomial nonlinearity
178
Targeted enhancement of oleoylethanolamide mobilization in proximal small intestine induces across-meal satiety in rats
179
Targeted Enrollment of Medical Students for Rural China: Prospects and Challenges
180
Targeted epidermal growth factor receptor therapy in malignant pleural mesothelioma: Where do we stand?
181
Targeted ethnography as a critical step to inform cultural adaptations of HIV prevention interventions for adults with severe mental illness
182
Targeted Expression of BikDD Eradicates Pancreatic Tumors in Noninvasive Imaging Models
183
Targeted expression of csCSF-1 in op/op mice ameliorates tooth defects
184
Targeted Fluoromagnetic Nanoparticles for Imaging of Breast Cancer MCF-7 Cells
185
Targeted food supplementation through National Nutrition Program and pregnancy weight gain status in selected upazilas
186
Targeted Fully Homomorphic Encryption Based on a Double Decryption Algorithm for Polynomials
187
Targeted gene analysis in Ulmus americana and U. pumila tissues
188
Targeted gene delivery in the cricket brain, using in vivo electroporation
189
Targeted gene delivery to the brain using CDX-modified chitosan nanoparticles
190
Targeted Gene Disruption in the Development of Mouse Models to Elucidate the Role of Receptor Guanylyl Cyclase Signaling Pathways in Physiological Function
191
Targeted Gene Disruption of theCaenorhabditis elegansl-Isoaspartyl Protein Repair Methyltransferase Impairs Survival of Dauer Stage Nematodes
192
Targeted Gene Expression Profiling in the Rainbow Trout (Oncorhynchus mykiss) Ovary During Maturational Competence Acquisition and Oocyte Maturation
193
Targeted Gene Expression Using the GAL4/UAS System in the Silkworm Bombyx mori
194
Targeted Gene Therapy of Cancer: Second Amendment toward Holistic Therapy
195
Targeted gene therapy: frontiers in the development of ‘smart drugs’
196
Targeted gene transduction of mammalian cells expressing the HER2/neu receptor by filamentous phage
197
Targeted gene-delivery strategies for angiostatic cancer treatment
198
Targeted glycoproteomics: Serial lectin affinity chromatography in the selection of O-glycosylation sites on proteins from the human blood proteome
199
Targeted GOES Satellite Observations to Improve Hurricane Track Forecast: A Case Study of Hurricane Floyd
200
Targeted heat transfer augmentation in circular tubes using a corona jet
201
Targeted high-efficiency, homogeneous myocardial gene transfer
202
Targeted human cerebrospinal fluid proteomics for the validation of multiple Alzheimerʹs disease biomarker candidates
203
Targeted hyperthermia using metal nanoparticles
204
Targeted imaging
205
Targeted immunosuppression: No longer naïve
206
Targeted improvement of Steinernema carpocapsae for control of the pecan weevil, Curculio caryae (Horn) (Coleoptera: Curculionidae) through hybridization and bacterial transfer
207
Targeted in vitro photodynamic therapy via aptamer-labeled, porphyrin-loaded virus capsids
208
Targeted Inactivation of Fh1 Causes Proliferative Renal Cyst Development and Activation of the Hypoxia Pathway
209
Targeted Inactivation of Mdm2 RING Finger E3 Ubiquitin Ligase Activity in the Mouse Reveals Mechanistic Insights into p53 Regulation
210
Targeted inactivation of the murine cardiac myosin-binding protein C gene leads to hypertrophic cardiomyopathy
211
Targeted inactivation of vitamin D hydroxylases in mice
212
Targeted induction of apoptosis for cancer therapy: current progress and prospects
213
Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection: A potential mechanism of tumor-immune privilege
214
Targeted inhibition of hedgehog signaling by cyclopamine prodrugs for advanced prostate cancer Original Research Article
215
Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: Potential role in prevention and therapy of cancer
216
Targeted Inhibition of β-Adrenergic Receptor Kinase-1–Associated Phosphoinositide-3 Kinase Activity Preserves β-Adrenergic Receptor Signaling and Prolongs Survival in Heart Failure Induced by Calsequestrin Overexpression Original Research Article
217
Targeted integration of adenovirus vectors in hematopoietic stem cells
218
Targeted intervention for multiple language disorders: a case study
219
Targeted intervention for the ultra poor in rural Bangladesh: Does it make any difference in their health-seeking behaviour?
220
Targeted intracellular catalase delivery protects neonatal rat myocytes from hypoxia-reoxygenation and ischemia-reperfusion injury
221
Targeted Intracellular Heat Transfer in Cancer Therapy: Assessment of Asparagine-laminated Gold Nanoparticles in Cell Model of T cell Leukemia
222
Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomics
223
Targeted Iron Oxide Particles for In Vivo Magnetic Resonance Detection of Atherosclerotic Lesions With Antibodies Directed to Oxidation-Specific Epitopes
224
Targeted knockdown of canine KIT (stem cell factor receptor) using RNA interference
225
Targeted knockdown of canine KIT (stem cell factor receptor) using RNA interference
226
Targeted Left Ventricular Lead Placement to Guide Cardiac Resynchronization Therapy: The TARGET Study: A Randomized, Controlled Trial
227
Targeted lipidomics approach for endogenous N-acyl amino acids in rat brain tissue
228
Targeted Lung Cancer Treatments and Eye Metastasis
229
Targeted manipulation of apoptotic pathways by using High Intensity Focused Ultrasound in cancer treatment
230
Targeted Marketing in Herbal Medicine; Application for Grounded Theory and K- Mean Algorithm
231
Targeted mass spectral ratio analysis: A new tool for gas chromatography—mass spectrometry
232
Targeted mass treatment for syphilis with oral azithromycin
233
Targeted material design of flyash filled composites for friction braking application by non-linear regression optimization technique
234
Targeted metabolic profiling of phenolics in urine and plasma after regular consumption of cocoa by liquid chromatography–tandem mass spectrometry
235
Targeted metabolite analysis of Catharanthus roseus and its biological potential
236
Targeted metabolomic analysis of plasma samples for the diagnosis of inherited metabolic disorders
237
Targeted Methylation and Gene Silencing of VEGF-A in Human Cells by Using a Designed Dnmt3a–Dnmt3L Single-Chain Fusion Protein with Increased DNA Methylation Activity
238
Targeted microbubbles for ultrasound mediated gene transfection and apoptosis induction in ovarian cancer cells
239
Targeted microbubbles for ultrasound mediated gene transfection and apoptosis induction in ovarian cancer cells
240
Targeted mining of drought stress-responsive genes from EST resources in Cleistogenes songorica
241
Targeted Modification of Homogalacturonan by Transgenic Expression of a Fungal Polygalacturonase Alters Plant Growth
242
Targeted Molecular Imaging Agents for Cellular-Scale Bimodal Imaging
243
Targeted multidimensional gas chromatography for the quantitative analysis of suspected allergens in fragrance products
244
Targeted Multidimensional Gas Chromatography Using Microswitching and Cryogenic Modulation
245
Targeted multimodal imaging modalities
246
Targeted mutagenesis of the Clostridium acetobutylicum acetone–butanol–ethanol fermentation pathway
247
Targeted mutation breeding of horticultural plants
248
Targeted MYCN expression affects cytotoxic potential of chemotherapeutic drugs in neuroblastoma cells
249
Targeted Myocardial Microinjections of a Biocomposite Material Reduces Infarct Expansion in Pigs
250
Targeted naltrexone treatment of early problem drinkers
251
Targeted Nanoblobs Spot Treat Cancer and Heart Disease
252
Targeted nanocarriers for imaging and therapy of vascular inflammation
253
Targeted Nanoparticle Therapy with Betaine-Conjugated Gold Nanoparticles Reduces Inflammation and Makes Immunomodulation in Heatstroke in Mice
254
Targeted nanoparticles for cancer therapy
255
Targeted nanoparticles for simultaneous delivery of chemotherapeutic and hyperthermia agents – An in vitro study
256
Targeted nanoparticles with novel non-peptidic ligands for oral delivery
257
Targeted nanotechnology for cancer imaging
258
Targeted Next Generation Sequencing (NGS) to Diagnose Hereditary Hemolytic Anemias
259
Targeted Next Generation Sequencing Reveals a Novel Intragenic Deletion of the TPO Gene in a Family with Intellectual Disability
260
Targeted Next-Generation Sequencing Identifies Pathogenic Variants in Familial Congenital Heart Disease
261
Targeted NF-κB inhibition of asthmatic serum-mediated human monocyte-derived dendritic cell differentiation in a transendothelial trafficking model
262
Targeted nNOS gene transfer into the cardiac vagus rapidly increases parasympathetic function in the pig
263
Targeted nucleic acid delivery into tumors: new avenues for cancer therapy
264
Targeted Nucleotide Exchange in Saccharomyces cerevisiae Directed by Short Oligonucleotides Containing Locked Nucleic Acids Original Research Article
265
Targeted Nucleotide Repair of cyc1 Mutations in Saccharomyces cerevisiae Directed by Modified SingleStranded DNA Oligonucleotides
266
Targeted nutrition in the critically ill: a therapeutic modality for the new millennium?
267
Targeted Nutritional and Behavioral Feeding Intervention fora Child with Autism Spectrum Disorder
268
Targeted Optical Imaging Agents in Cancer: Focus on Clinical Applications
269
Targeted Overactivity of β Cell KATP Channels Induces Profound Neonatal Diabetes
270
Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy
271
Targeted Overexpression of Phospholamban to Mouse Atrium Depresses Ca2+Transport and Contractility
272
Targeted peptides for the quantitative evaluation of casein plasminolysis in drinking milk
273
Targeted pharmacological reversal of electrical remodeling after cardioversion—Rationale and design of the Flecainide Short-Long (Flec-SL) trial
274
Targeted phase II metabolites profiling as new screening strategy to investigate natural steroid abuse in animal breeding Original Research Article
275
Targeted photodynamic therapy via receptor mediated delivery systems
276
Targeted Photothermal Therapy of Melanoma in C57BL/6 Mice using Fe3O4@Au Core-shell Nanoparticles and Near-infrared Laser
277
Targeted prenatal herpes simplex virus testing: Can we identify women at risk of transmission to the neonate?
278
Targeted processor architectures for high-performance controller implementation
279
Targeted profiling of polar intracellular metabolites using ion-pair-high performance liquid chromatography and -ultra high performance liquid chromatography coupled to tandem mass spectrometry: Applications to serum, urine and tissue extracts
280
Targeted programs v the basic income guarantee: an examination of the efficiency costs of different forms of redistribution
281
Targeted Protein Functionalization Using His-Tags
282
Targeted proteomics for metabolic pathway optimization: Application to terpene production
283
Targeted quantitative analysis of eicosanoid lipids in biological samples using liquid chromatography–tandem mass spectrometry
284
Targeted quantitative analysis of fatty acids in atherosclerotic plaques by high sensitivity liquid chromatography/tandem mass spectrometry
285
Targeted quantitative analysis of superoxide dismutase 1 in cisplatin-sensitive and cisplatin-resistant human ovarian cancer cells
286
Targeted radiofrequency field mapping using 3D reduced field-of-view-catalyzed double-angle method
287
Targeted radio-nuclide therapy of skeletal metastases
288
Targeted reduction of complex models with time scale hierarchy – a case study
289
Targeted reinnervation for enhanced prosthetic arm function in a woman with a proximal amputation: a case study
290
Targeted Remodeling of Human β-Globin Promoter Chromatin Structure Produces Increased Expression and Decreased Silencing
291
Targeted removal of bioavailable metal as a detoxification strategy for carbon nanotubes Original Research Article
292
Targeted renal therapies through microbubbles and ultrasound
293
Targeted RNAi of the Mitogen-activated Protein Kinase Pathway Genes in Acute Myeloid Leukemia Cells
294
Targeted Sampling Protocol as Prelude to Bacterial Source Tracking with Enterococcus faecalis
295
Targeted saving by renters for housing purchase in Japan
296
Targeted Screening for Predominant CYP1B1 Mutations in Primary Congenital Glaucoma
297
Targeted Screening of Membrane Proteins of Haemophilus Ducreyi with the Aim of Drug Targets Identification
298
Targeted separation of antibacterial peptide from protein hydrolysate of anchovy cooking wastewater by equilibrium dialysis
299
Targeted Shapiro filter in an ocean model
300
Targeted silencing of TRPM7 ion channel induces replicative senescence and produces enhanced cytotoxicity with gemcitabine in pancreatic adenocarcinoma
301
Targeted Single-Cell Microchemical Analysis: MS-Based Peptidomics of Individual Paraformaldehyde-Fixed and Immunolabeled Neurons Original Research Article
302
Targeted Solid Lipid Nanoparticles Formulation for Colon Cancer Treatment and Cytotoxicity Assessment Using HT29 Cell Line
303
Targeted sonocatalytic cancer cell injury using avidin-conjugated titanium dioxide nanoparticles
304
Targeted sonocatalytic cancer cell injury using avidin-conjugated titanium dioxide nanoparticles
305
Targeted sonodynamic therapy using protein-modified TiO2 nanoparticles
306
Targeted sonodynamic therapy using protein-modified TiO2 nanoparticles
307
Targeted spray technology to reduce pesticide in runoff from dormant orchards
308
Targeted stable-isotope dilution GC–MS/MS analysis of the endocannabinoid anandamide and other fatty acid ethanol amides in human plasma
309
Targeted Stimulation of Meiotic Recombination
310
Targeted study to evaluate the cardiovascular risk factor status among patients and efficacy of statins in attaining goal lipid levels in a regional hospital in Sultanate of Oman
311
Targeted synthesis of 2,3-disubstituted 2-phospholenes using catalytic cycloalumination of acetylenes
312
Targeted therapeutic approaches for hormone-refractory prostate cancer
313
Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. A meta-analysis of published trials
314
Targeted therapies for advanced non-small-cell lung cancer: Current status and future implications
315
Targeted Therapies for Hepatitis C Reach the Clinic
316
Targeted therapies for kidney cancer in urologic practice
317
Targeted therapies for squamous cell carcinoma of the head and neck: Current knowledge and future directions
318
Targeted therapies for the treatment of cancer
319
Targeted therapies in bladder cancer—an update
320
Targeted therapies in melanoma
321
Targeted therapies in non-muscle-invasive bladder cancer according to the signaling pathways
322
Targeted therapies of cancer: Angiogenesis inhibition seems not enough
323
Targeted therapy against chemoresistant colorectal cancers: Inhibition of p38α modulates the effect of cisplatin in vitro and in vivo through the tumor suppressor FoxO3A
324
Targeted therapy comes of age in scleroderma
325
Targeted therapy for colorectal cancer: mapping the way
326
Targeted Therapy for Intracellular Bacterial Pathogens
327
Targeted therapy for soft tissue sarcomas in adolescents and young adults
328
Targeted therapy for systemic sclerosis
329
Targeted therapy for uveal melanoma
330
Targeted therapy in advanced non-small cell lung cancer (NSCLC): Where do we stand?
331
Targeted therapy in metastatic colorectal cancer – An example of personalised medicine in action
332
Targeted therapy in metastatic renal carcinoma
333
Targeted therapy of multiple myeloma based upon tumor-microenvironmental interactions
334
Targeted thiolation of graphene oxide and its utilization as precursor for graphene/silver nanoparticles composites Original Research Article
335
Targeted three-dimensional liquid chromatography: A versatile tool for quantitative trace analysis in complex matrices
336
Targeted toxins in pain
337
Targeted transfection of the IL-3 gene into primary human hematopoietic progenitor cells through the c-kit receptor
338
Targeted transfers and the fiscal response to the great recession
339
Targeted treatment for incontinence beckons
340
Targeted treatment of catastrophizing for the management of chronic pain Original Research Article
341
Targeted treatments for symptom domains in child and adolescent autism
342
Targetedtransfersandthefiscalresponsetothegreatrecession
343
Target–flanker discriminability affects conflict size but not sustained suppression
344
Target-guided isolation and purification of antioxidants from Selaginella sinensis by offline coupling of DPPH-HPLC and HSCCC experiments
345
Target-guided separation of Bougainvillea glabra betacyanins by direct coupling of preparative ion-pair high-speed countercurrent chromatography and electrospray ionization mass-spectrometry
346
Target-induced anergy of natural killer cytotoxic function is restricted to the NK—target conjugate subset
347
Target-induced aptamer release strategy based on electrochemical detection of staphylococcal enterotoxin B using GNPs-ZrO2-Chits film
348
Target-induced conformational adaptation of calmodulin revealed by the crystal structure of a complex with nematode Ca2+/calmodulin-dependent kinase kinase peptide
349
Target-induced selection of ligands from a dynamic combinatorial library of mono- and bi-conjugated oligonucleotides
350
Targeting [AuCl2(CN)2]− units as halophilic building blocks in coordination polymers
351
Targeting a cornerstone of radiation resistance: Cancer stem cell
352
Targeting a Dual Detector of Skin and CO2 to Modify Mosquito Host Seeking
353
Targeting a marker of the tumour neovasculature using a novel anti-human CD105-immunotoxin containing the non-toxic type 2 ribosome-inactivating protein nigrin b
354
Targeting a polyketide synthase gene for Aspergillus carbonarius quantification and ochratoxin A assessment in grapes using real-time PCR
355
Targeting a Prokaryotic Protein in a Eukaryotic Pathogen: Identification of Lead Compounds against Cryptosporidiosis
356
Targeting a Prokaryotic Protein in a Eukaryotic Pathogen: Identification of Lead Compounds against Cryptosporidiosis Original Research Article
357
Targeting a ruthenium complex to the nucleus with short peptides Original Research Article
358
Targeting a Uniquely Nonspecific Prenyl Synthase with Bisphosphonates to Combat Cryptosporidiosis Original Research Article
359
Targeting Acceptance, Mindfulness, and Values-Based Action in Chronic Pain: Findings of Two Preliminary Trials of an Outpatient Group-Based Intervention Original Research Article
360
Targeting ACE and ECE with dual acting inhibitors
361
Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer
362
Targeting ADAMS and ERBBs in lung cancer
363
Targeting adolescent risk-taking behaviors: the contributions of egocentrism and sensation-seeking
364
Targeting Advanced Glycation End Products in Cardiac Surgery: The Unexplored Alternative
365
Targeting agricultural research based on potential impacts on poverty reduction: Strategic program priorities by agro-ecological zone in Nigeria
366
Targeting agricultural research to benefit poor farmers: Relating poverty mapping to maize environments in Mexico
367
Targeting agri-environmental policy : An analysis relating to the use of Geographical Information Systems
368
Targeting airline advertising copy
369
Targeting ALT: The role of alternative lengthening of telomeres in pathogenesis and prevention of cancer
370
Targeting Altered Mitochondrial Biogenesis in the Brain of Diabetic Rats: Potential Effect of Pioglitazone and Exendin-4
371
Targeting Alzheimer’s disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238 Original Research Article
372
Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells
373
Targeting an Old Mechanism in a New Disease—Protection of Glutamatergic Dysfunction in Depression
374
Targeting and anti-tumor efficacy of liposomal 5′-O-dipalmitoylphosphatidyl 2′-C-cyano-2′-deoxy-1-β-d-arabino-pentofuranosylcytosine in mice lung bearing B16BL6 melanoma
375
Targeting and impacts of AgI cloud seeding based on rain chemical composition and cloud top phase characterization
376
Targeting and implementing payments for ecosystem services: Opportunities for bundling biodiversity conservation with carbon and water services in Madagascar
377
Targeting and Inhibiting Plasmodium berghei Growth in Balb/c Mice Using Kojic Acid-Solid Lipid Nanoparticles and Kojic Acid-Nanostructured Lipid Carriers
378
Targeting and scheduling problem for field artillery
379
Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
380
Targeting Aneuploidy for Cancer Therapy
381
Targeting angiogenesis in pancreatic cancer
382
Targeting Apo2L/TRAIL receptors by soluble Apo2L/TRAIL
383
Targeting apoptosis pathways by Celecoxib in cancer
384
Targeting apoptosis pathways by natural compounds in cancer: Marine compounds as lead structures and chemical tools for cancer therapy
385
Targeting apoptosis pathways in cancer by Chinese medicine
386
Targeting apoptosis pathways in cancer stem cells
387
Targeting apoptosis pathways in childhood malignancies
388
Targeting apoptosis pathways in glioblastoma
389
Targeting apoptosis pathways in lung cancer
390
Targeting apoptosis pathways in pancreatic cancer
391
Targeting apoptosis proteins in hematological malignancies
392
Targeting Apoptosis via Chemical Design: Inhibition of Bid-Induced Cell Death by Small Organic Molecules Original Research Article
393
Targeting apoptotic and autophagic pathways for cancer therapeutics
394
Targeting ASIC1a Reduces Innate Fear and Alters Neuronal Activity in the Fear Circuit
395
Targeting ATR in DNA damage response and cancer therapeutics
396
Targeting autoimmune diseases through nutraceuticals
397
Targeting autophagy for breast cancer prevention and therapy: From classical methods to phytochemical agents
398
Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells
399
Targeting Bacterial Virulence: Inhibitors of Type III Secretion in Yersinia Original Research Article
400
Targeting Bcl-2 family proteins in adult T-cell leukemia/lymphoma: In vitro and in vivo effects of the novel Bcl-2 family inhibitor ABT-737
401
Targeting biological control across diverse landscapes: the release, establishment, and early success of two insects on mesquite (Prosopis spp.) insects in Australian rangelands
402
Targeting Brain Regions and Symptoms: Neuronal Single-Unit Recordings and Deep Brain Stimulation in Obsessive-Compulsive Disorder
403
Targeting Breast and Cervical Cancer Screening to Elderly Poor Black Women: Who Will Participate?
404
Targeting Breast and Prostate Cancers Through Their Hormone Receptors
405
Targeting Breast Cancer With Bio-inspired Virus Nanoparticles
406
Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis
407
Targeting cancer cells by exploiting their resistance
408
Targeting cancer cells through iron(III) complexes of di(picolyl)amine modified silica core–shell nanospheres
409
Targeting Cancer Cells with Dendrimers
410
Targeting cancer cells with nucleic acid aptamers
411
Targeting cancer cells with transferrin conjugates containing the non-toxic type 2 ribosome-inactivating proteins nigrin b or ebulin l
412
Targeting cancer stem cells by curcumin and clinical applications
413
Targeting Cancer Stem Cells, The Major Leap Toward a Cure
414
Targeting cancer using cholesterol conjugates
415
Targeting Capacity and Conservation of PreP Homologues Localization in Mitochondria of Different Species
416
Targeting cathepsin S induces tumor cell autophagy via the EGFR–ERK signaling pathway
417
Targeting cell regulation promotes pathogen survival in macrophages
418
Targeting c-FLIP in cancer
419
Targeting Cholesteryl Ester Transfer Protein for the Prevention and Management of Cardiovascular Disease Review Article
420
Targeting cogeneration and waste utilization through process integration
421
Targeting Colorectal Cancer Cell Lines Using Nanobodies; AgSK1as a Potential Target
422
Targeting commercial sex-workers in Goa, India: time for a strategic rethink?
423
Targeting conservation agriculture in the context of livelihoods and landscapes
424
Targeting conservation efforts in the presence of threshold effects and ecosystem linkages
425
Targeting Conservation Investments in Heterogeneous Landscapes: A DistanceFunction Approach and Application to Watershed Management
426
Targeting conservation payments to achieve multiple outcomes Original Research Article
427
Targeting conservation–development initiatives in tropical forests: insights from analyses of rain forest use and economic reliance among Amazonian peasants
428
Targeting Copper Dyshomeostasis as a Pathophysiological Basis of Childhood Obesity: Latest Facts
429
Targeting C-type lectin receptors with multivalent carbohydrate ligands
430
Targeting cultural changes supportive of the healthiest lifestyle patterns. A biosocial evidence-base for prevention of obesity
431
Targeting customers via discovery knowledge for the insurance industry
432
TARGETING CUSTOMERS: A FUZZY CLASSIFICATION APPROACH
433
Targeting cyclooxygenase-2 in human neoplasia: Rationale and promise
434
Targeting cytochrome P450 enzymes: A new approach in anti-cancer drug development Review Article
435
Targeting cytokines in asthma therapy: round one
436
Targeting deeper the human serum fucome by a liquid-phase multicolumn platform in combination with combinatorial peptide ligand libraries
437
Targeting delivery of paclitaxel into tumor cells via somatostatin receptor endocytosis Original Research Article
438
Targeting dendritic cells with biomaterials: developing the next generation of vaccines
439
Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations
440
Targeting development assistance to meet WSSD goals for large marine ecosystems and small island developing states
441
Targeting disadvantage in agriculture
442
Targeting dispositions for drug-involved offenders: A field trial of the Risk and Needs Triage (RANT)™
443
Targeting DNA abasic site by myricetin: Sequence-dependent ESIPT emission
444
Targeting DNA Bulged Microenvironments with Synthetic Agents: Lessons from a Natural Product Original Research Article
445
Targeting DNA methylation in cancer
446
Targeting DNA repair in breast cancer: A clinical and translational update
447
Targeting DNA repair pathways: A novel approach to reduce cancer therapeutic resistance
448
Targeting DNA topoisomerase II with podophyllotoxin aza-analogue
449
Targeting duplex DNA with DNA-PNA chimeras? Physico-chemical characterization of a triplex DNA-PNA/DNA/DNA
450
Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence
451
Targeting education: The politics of performance and the prospects of ‘Education For All’
452
Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer
453
Targeting efflux pumps—In vitro investigations with acridone derivatives and identification of a lead molecule for MDR modulation Original Research Article
454
Targeting energy metabolism in Huntingtonʹs disease
455
Targeting enforcement to improve compliance with environmental regulations
456
Targeting enzymes to the right compartment: Metabolic engineering for itaconic acid production by Aspergillus niger
457
Targeting epidermal growth factor receptor—are we missing the mark?
458
Targeting Epigenetic Misregulation in Synovial Sarcoma
459
Targeting ER stress induced apoptosis and inflammation in cancer
460
Targeting ergonomics interventions—learning from health promotion
461
Targeting excessive free radicals with peels and juices of citrus fruits: Grapefruit, lemon, lime and orange
462
Targeting farnesoid X receptor for liver and metabolic disorders
463
Targeting fibroblast-like synovial cells at sites of inflammation with peptide targeted liposomes results in inhibition of experimental arthritis
464
Targeting for carbon sequestration retrofit planning in the power generation sector for multi-period problems
465
Targeting for cogeneration potential through total site integration
466
Targeting for pollution prevention through process simulation
467
Targeting FOXO Kills Two Birds with One Stone Review Article
468
Targeting fungi: A challenge
469
Targeting G protein coupled receptor-related pathways as emerging molecular therapies
470
Targeting GABARAPL1/HIF-2a axis to induce tumor cell apoptosis in nasopharyngeal carcinoma
471
Targeting Gastric Cancer Stem Cells through Developmental Pathways: Hypothesis
472
Targeting gastrin-releasing peptide receptors of prostate cancer cells for photodynamic therapy with a phthalocyanine–bombesin conjugate
473
Targeting GATA-1 to binding sites in nuclear chromatin
474
Targeting GD2 ganglioside and aurora A kinase as a dual strategy leading to cell death in cultures of human neuroblastoma cells
475
Targeting gene expression to the vascular wall in transgenic mice using the murine preproendothelin-1 promoter
476
Targeting gene expression using HSV vectors
477
Targeting gene therapy for hepatocarcinoma cells with the E. coli purine nucleoside phosphorylase suicide gene system directed by a chimeric α-fetoprotein promoter
478
Targeting genetic resource conservation in widespread species: a case study of Cedrela odorata L.
479
Targeting Glycosylation Pathways and the Cell Cycle: Sugar-Dependent Activity of Butyrate-Carbohydrate Cancer Prodrugs Original Research Article
480
Targeting gut microbiota in hepatocellular carcinoma: probiotics as a novel therapy
481
Targeting heat shock factor 1 with a triazole nucleoside analog to elicit potent anticancer activity on drug-resistant pancreatic cancer
482
Targeting heat shock proteins in cancer
483
Targeting HER-2/neu-overexpressing breast cancer cells by an antisense iron responsive element-directed gene expression
484
Targeting high-performance liquid chromatography–high-resolution mass spectrometry–solid-phase extraction–nuclear magnetic resonance analysis with high-resolution radical scavenging profiles—Bioactive secondary metabolites from the endophytic fungus Penic
485
Targeting HIV: Beyond Protease and Reverse Transcriptase Inhibitors
486
Targeting HPC with the help of nanoparticles: An overview
487
Targeting HSP90 to Halt Neurodegeneration
488
Targeting Human Telomerase Reverse Transcriptase by a Simple siRNA Expression Cassette in HepG2 Cells
489
Targeting IL-17 in psoriasis: From cutaneous immunobiology to clinical application
490
Targeting IL-2 to the endoplasmic reticulum confines autocrine growth stimulation to NK-92 cells
491
Targeting Immunosupportive Cancer Therapies: Accentuate the Positive, Eliminate the Negative
492
Targeting improved DMFC performance
493
Targeting in the presence of noise
494
Targeting inflation by forecast feedback rules in small open economies
495
Targeting inflation over the short, medium and long term
496
Targeting inflation: Comparative control exercises on models of the UK economy
497
Targeting iNKT cells for the treatment of sickle cell disease
498
Targeting innovation and implications for capability development
499
Targeting integrins: Insights into structure and activity of cyclic RGD pentapeptide mimics containing azabicycloalkane amino acids Original Research Article
500
Targeting intelligence gathering in a dynamic competitive environment
501
Targeting interferon regulatory factors to inhibit activation of the type I IFN response: Implications for treatment of autoimmune disorders
502
Targeting Investments for Neighborhood Revitalization
503
Targeting Jab1/CSN5 in nasopharyngeal carcinoma
504
Targeting JAK3 with JANEX-1 for prevention of autoimmune type 1 diabetes in NOD mice
505
Targeting Key Genes in the Early Diagnosis and Treatment of Lung Cancer with a Focus on Personalized Medicine: a Review Article
506
Targeting large molecules to mitochondria
507
Targeting large molecules to mitochondria
508
Targeting leukocyte recruitment in the treatment of psoriasis
509
Targeting Lifestyle Change in Patients With Depression
510
Targeting Lifestyle Intervention for Obesity Control Among School Age Children
511
Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth
512
Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table
513
Targeting lipoic acid to mitochondria: Synthesis and characterization of a triphenylphosphonium-conjugated α-lipoyl derivative
514
Targeting liposomes to tumor endothelial cells for neutron capture therapy
515
Targeting Lipoxygenases with Care
516
Targeting Liver Cancer: First Steps toward a miRacle?
517
Targeting long non-coding RNAs as new modulators in anti-EGFR resistance mechanisms
518
Targeting low high-density lipoprotein cholesterol for therapy: lessons from the Veterans Affairs High-density Lipoprotein Intervention Trial
519
Targeting low-arsenic aquifers in Matlab Upazila, Southeastern Bangladesh
520
Targeting Malaria with Polyamines
521
Targeting Mcl-1 for multiple myeloma (MM) therapy: Drug-induced generation of Mcl-1 fragment Mcl-1128–350 triggers MM cell death via c-Jun upregulation
522
Targeting metabolomics analysis of the sunscreen agent 2-ethylhexyl 4-(N,N-dimethylamino)benzoate in human urine by automated on-line solid-phase extraction–liquid chromatography–tandem mass spectrometry with liquid chromatography–time-of-flight/mass spec
523
Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen: Bander NH, Trabulsi EJ, Kostakoglu L, Yao D, Vallabhajosula S, Smith-Jones P, Joyce MA, Milowsky M, Nanus DM
524
Targeting MgrA-Mediated Virulence Regulation in Staphylococcus aureus Original Research Article
525
Targeting micro-sectioning—A technique to study subsurface features in worn specimens
526
Targeting minor histocompatibility antigens in graft versus tumor or graft versus leukemia responses
527
Targeting Mitochondrial and Brain Injury Markers in Acquired Brain Injuries: A Randomized, Double-Blind, Placebo-Controlled Study with Melatonin
528
Targeting mitochondrial biogenesis for preventing and treating insulin resistance in diabetes and obesity: Hope from natural mitochondrial nutrients
529
Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation
530
Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation
531
Targeting Mitochondrial Oxidative Stress in Heart Failure: Throttling the Afterburner
532
Targeting Mitotic Exit Leads to Tumor Regression In Vivo: Modulation by Cdk1, Mastl, and the PP2A/B55α,δ Phosphatase
533
Targeting molecular pathways in endometrial cancer: A focus on the FGFR pathway
534
Targeting Monocyte Recruitment in CNS Autoimmune Disease
535
Targeting moving targets in chaotic dynamical systems
536
Targeting mRNA to regulate iron and oxygen metabolism
537
Targeting Multiple Biofilm Pathways
538
Targeting multiple genetic aberrations in isolated tumor cells by spectral fluorescence in situ hybridization
539
Targeting NAD Biosynthesis in Bacterial Pathogens: Structure-Based Development of Inhibitors of Nicotinate Mononucleotide Adenylyltransferase NadD Original Research Article
540
Targeting Nanostrategies for Imaging of Atherosclerosis
541
Targeting nitric oxide synthase with 99mTc/Re-tricarbonyl complexes containing pendant guanidino or isothiourea moieties
542
Targeting nitric oxide to cancer cells: cytotoxicity studies of glyco-S-nitrosothiols
543
Targeting nitroxides to mitochondria: location, location, location, and …concentration: Highlight Commentary on “Mitochondria superoxide dismutase mimetic inhibits peroxide-induced oxidative damage and apoptosis: Role of mitochondrial superoxide”
544
Targeting nominal income: A closer look
545
Targeting Nonclassical Oncogenes for Therapy in T-ALL
546
Targeting novel and established therapies for non-small cell lung cancer
547
Targeting Occupations in Regional and Community Economic Development
548
Targeting of a Nicotiana plumbaginifolia H+-ATPase to the Plasma Membrane Is Not by Default and Requires Cytosolic Structural Determinants
549
Targeting of Adenovirus Serotype 5 Pseudotyped with Short Fiber from Serotype 41 to c-erbB2-Positive Cells using Bispecific Single-Chain Diabody
550
Targeting of androgen receptor in bone reveals a lack of androgen anabolic action and inhibition of osteogenesis: A model for compartment-specific androgen action in the skeleton
551
Targeting of children in filariasis mass drug administration
552
Targeting of cholera toxin A (ctxA) gene by zinc finger nuclease: pitfalls of using gene editing tools in prokaryotes
553
Targeting of Cytotoxic Luteinizing Hormone-Releasing Hormone Analogs to Breast, Ovarian, Endometrial, and Prostate Cancers
554
Targeting of diethylene triamine pentaacetic acid encapsulated in liposomes to rat liver: an effective strategy to prevent bone deposition and increase urine elimination of plutonium in rats
555
Targeting of epidermal growth factor receptor by cyclopentenone prostaglandin 15-Deoxy-Δ12,14-prostaglandin J2 in human oral squamous carcinoma cells
556
Targeting of Escherichia coli F4 fimbriae to Fcγ receptors enhances the maturation of porcine dendritic cells
557
Targeting of Escherichia coli F4 fimbriae to Fcγ receptors enhances the maturation of porcine dendritic cells
558
Targeting of fluorescent palygorskite polyethyleneimine nanocomposite to cancer cells
559
Targeting of food aid in rural Ethiopia: chronic need or inertia?
560
Targeting of heat-shock protein 32/heme oxygenase-1 in canine mastocytoma cells is associated with reduced growth and induction of apoptosis
561
Targeting of hormone replacement therapy immediately after menopause
562
Targeting of Lin−Sca+ hematopoietic stem cells with bispecific antibodies to injured myocardium
563
Targeting of membrane type1-matrix metalloproteinase (MT1-MMP) using superparamagnetic nanoparticles in human liver cancer cells
564
Targeting of mixed sequence double-stranded DNA using pyrene-functionalized 2-amino(alpha)-L-LNA
565
Targeting of multiple metabolites in neural cells monitored by using protein-based carbon nanotubes
566
Targeting of observations for accidental atmospheric release monitoring
567
Targeting of polyamidoamine–DNA nanoparticles using the Staudinger ligation: Attachment of an RGD motif either before or after complexation Original Research Article
568
Targeting of proteins into and within the chloroplast
569
Targeting of sugar- and charge-modified albumins to fibrotic rat livers: the accessibility of hepatic cells after chronic bile duct ligation
570
Targeting of superoxide dismutase to the liver results in anti-inflammatory effects in rats with fibrotic livers
571
Targeting of the actin cytoskeleton during infection by Salmonella strains
572
Targeting of the highly conserved threonine 302 residue of cytochromes P450 2B family during mechanism-based inactivation by aryl acetylenes
573
Targeting of the Tumor Suppressor GRHL3 by a miR-21-Dependent Proto-Oncogenic Network Results in PTEN Loss and Tumorigenesis
574
Targeting of therapeutic agents to bone to treat metastatic cancer
575
Targeting of vasculature in cancer and other angiogenic diseases
576
Targeting of Venom Phospholipases: The Strongly Anticoagulant Phospholipase A2 from Naja nigricollis Venom Binds to Coagulation Factor Xa to Inhibit the Prothrombinase Complex
577
Targeting oncogene dependence and resistance
578
Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation
579
Targeting Orphan Nuclear Receptors for Treatment of Metabolic Diseases and Autoimmunity Review Article
580
Targeting p53 as a therapeutic strategy in sensitizing TRAIL-induced apoptosis in cancer cells
581
Targeting p53 by PTD-mediated transduction
582
Targeting p73 in cancer
583
Targeting peptide nucleic acid-protein conjugates to structural features within duplex DNA Original Research Article
584
Targeting Pharmacological and Nanotechnology Based Therapeutics for Management of Hirsutism: A Comprehensive State-of-the-Art
585
Targeting phonological representations can help in the early stages of reading in a non–dominant language
586
Targeting Placental Growth Factor/Neuropilin 1 Pathway Inhibits Growth and Spread of Medulloblastoma
587
Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridization
588
Targeting Plasmodium host cells: survival within hepatocytes
589
Targeting Platelet Nitric Oxide Resistance With Ramipril: Unraveling Mechanisms of Atherothrombotic Risk Reduction With Angiotensin-Converting Enzyme Inhibitors
590
Targeting platelet/endothelial cell adhesion molecule 1 enhances cisplatin sensitivity of human nasopharyngeal carcinoma cells exposed to ionizing radiation
591
Targeting plug-in hybrid electric vehicle policies to increase social benefits
592
Targeting Plutella xylostella digestive enzymes by applying resistant Brassicaceae host cultivars
593
Targeting podocyte-associated diseases
594
Targeting poly(ADP-ribosyl)ation: a promising approach in cancer therapy
595
Targeting polymer therapeutics to bone
596
Targeting poverty alleviation in priority setting for agricultural research
597
Targeting poverty to improve maternal health in Sokoto State, Nigeria
598
Targeting Priority Populations to Reduce Disparities in Cardiovascular Care: Health Equity for All
599
Targeting programmed cell death pathways with experimental therapeutics: opportunities in high-risk neuroblastoma
600
Targeting prokaryotic choline oxidase into chloroplasts enhance the potential of photosynthetic machinery of plants to withstand oxidative damage
601
Targeting promiscuous signaling pathways in cancer: another Notch in the bedpost
602
Targeting Promising Bread Wheat (Triticum aestivum L.) Lines for Cold Climate Growing Environments Using AMMI and SREG GGE Biplot Analyses
603
Targeting proteins to mitochondria using TAT
604
Targeting P-Selectin During Coronary Interventions: The Elusive Link Between Inflammation and Platelets to Prevent Myocardial Damage
605
Targeting public investments by agro-ecological zone to achieve growth and poverty alleviation goals in rural India
606
Targeting quantitative synthesis for the one-step amination of fatty alcohols and dimethylamine Original Research Article
607
Targeting receptor tyrosine kinase signalling in small cell lung cancer (SCLC): What have we learned so far?
608
Targeting receptor-mediated endocytotic pathways with nanoparticles: Rationale and advances
609
Targeting resource investments to achieve sediment reduction and improved Great Barrier Reef health
610
Targeting Retroviral Zn Finger-DNA Interactions: A Small-Molecule Approach Using the Electrophilic Nature of trans-Platinum-Nucleobase Compounds Original Research Article
611
Targeting RNA with cysteine-constrained peptides
612
Targeting RNA with peptidomimetic oligomers in human cells
613
Targeting rural development interventions: Empirical agent-based modeling in Nigerien villages
614
Targeting senescence pathways to reverse drug resistance in cancer
615
Targeting signal transduction in the discovery of antiproliferative drugs Review Article
616
Targeting sites for conservation: Using a patch-based ranking scheme to assess conservation potential
617
Targeting sites for habitat creation: an investigation into alternative scenarios
618
Targeting Smokers with Low Readiness to Change with Tailored and Nontailored Self-Help Materials,
619
Targeting solid tumors via T cell receptor complementarity-determining region 3δ in an engineered antibody
620
Targeting soluble Aβ peptide with Tramiprosate for the treatment of brain amyloidosis
621
Targeting Specific PDZ Domains of PSD-95: Structural Basis for Enhanced Affinity and Enzymatic Stability of a Cyclic Peptide Original Research Article
622
Targeting Spending for Land Conservation
623
Targeting sphingosine-1-phosphate: A novel avenue for cancer therapeutics
624
Targeting SRC in glioblastoma tumors and brain metastases: Rationale and preclinical studies
625
Targeting Superoxide Dismutase to Renal Proximal Tubule Cells Inhibits Mitochondrial Injury and Renal Dysfunction Induced by Cisplatin
626
Targeting superoxide dismutase to renal proximal tubule cells inhibits nephrotoxicity of cisplatin and increases the survival of cancer-bearing mice
627
Targeting Survival: Integration Site Selection by Retroviruses and LTR-Retrotransposons
628
Targeting survivin in cancer
629
Targeting synthetic analogues of the metallo-sulfur active sites of nickel enzymes capable of important catalysis
630
Targeting Systemically Administered Proteins to Bone by Bisphosphonate Conjugation
631
Targeting Systolic Blood Pressure: The Key to Controlling Combined Systolic/Diastolic Hypertension
632
Targeting Telomerase via Its Key RNA/DNA Heteroduplex
633
Targeting the ‘upper-turn-around’ in atrioventricular nodal reentrant tachycardia
634
Targeting the 90 kDa heat shock protein improves photodynamic therapy
635
Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells
636
Targeting the atherosclerotic process in clinical practice. A new look at established agents
637
Targeting the Bacterial Z-Ring
638
Targeting the ceramide system in cancer
639
Targeting the C-terminal focal adhesion kinase scaffold in pancreatic cancer
640
Targeting the dimerization interface for irreversible inhibition of HIV-1 protease
641
Targeting the DNA minor groove with fused ring dicationic compounds: Comparison of in silico screening and a high-resolution crystal structure
642
Targeting the End: The Structure of the Ku80 C-Terminal Domain
643
Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma
644
Targeting the finite-deformation response of wavy biological tissues with bio-inspired material architectures
645
Targeting the gatekeeper residue in phosphoinositide 3-kinases Original Research Article
646
Targeting the IL-17/IFN-γ axis as a potential new clinical therapy for type 1 diabetes
647
Targeting the impactors: siderophile element signatures of lunar impact melts from Serenitatis
648
Targeting the integration of multi-period utility systems for site scale process integration
649
Targeting the lymphatics using dendritic polymers (dendrimers)
650
Targeting the maximum heat recovery for systems with heat losses and heat gains
651
Targeting the message: A receiver-centered process for public relations writing : William Thompson, White Plains, NY: Longman Publishers, 508 pp., $41.91, paperback 1996
652
Targeting the microenvironment in chronic lymphocytic leukemia offers novel therapeutic options
653
Targeting the molecular chaperone heat shock protein 90 (HSP90): Lessons learned and future directions
654
Targeting the mTOR signaling network in cancer
655
Targeting the neural cell adhesion molecule in cancer
656
Targeting the orexinergic system: Mainly but not only for sleep-wakefulness therapies
657
Targeting the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway: An emerging treatment strategy for squamous cell lung carcinoma
658
Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer
659
Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancer
660
Targeting the PI3K/Akt/mTOR Signaling Pathway: Applications of Nanotechnology
661
Targeting the PI3K-Akt pathway in human cancer: Rationale and promise
662
Targeting the poor using community information
663
Targeting the Proangiogenic VEGF-VEGFR Protein-Protein Interface with Drug-like Compounds by In Silico and In Vitro Screening Original Research Article
664
Targeting the Proliferation Inhibition of Chronic Myeloid Leukemia Cells by Bone Marrow Derived-Mesenchymal Stem Cells via ERK Pathway as a Therapeutic Strategy
665
Targeting the Proprotein Convertase Subtilisin/Kexin Type 9 for the Treatment of Dyslipidemia and Atherosclerosis
666
Targeting the RAF–MEK–ERK pathway in cancer therapy
667
Targeting the real exchange rate: theory and evidence
668
Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis
669
Targeting the specificity and function of fibroblast growth factor-1 (acidic FGF) by site-directed mutagenesis
670
Targeting the Sticky Fingers of HIV-1
671
Targeting the tat-binding site of bovine immunodeficiency virus TAR RNA with a shape-selective rhodium complex Original Research Article
672
Targeting the TGFβ signaling network in human neoplasia
673
Targeting the trimolecular complex
674
Targeting the tumor and its microenvironment by a dual-function decoy Met receptor
675
Targeting the tumor necrosis factor-related apoptosis-inducing ligand path in neuroblastoma
676
Targeting the Undruggable Proteome: The Small Molecules of My Dreams
677
Targeting the vulnerable in emergency situations: who is vulnerable?
678
Targeting the X-Linked Inhibitor of Apoptosis Protein through 4-Substituted Azabicyclo[5.3.0]alkane Smac Mimetics. Structure, Activity, and Recognition Principles
679
Targeting the young, the poor, the less educated: thinking beyond traditional media
680
Targeting the α-folate receptor with cyclopenta[g]quinazoline-based inhibitors of thymidylate synthase Original Research Article
681
Targeting thrombin and factor VIIa: design, synthesis, and inhibitory activity of functionally relevant indolizidinones
682
Targeting tissue factor to tumor vasculature
683
Targeting TNF-α suppresses the production of MMP-9 in human salivary gland cells
684
Targeting to sialoadhesin receptor improves antigen presentation to T cells
685
Targeting to sialoadhesin receptor improves antigen presentation to T cells
686
Targeting to sialoadhesin receptor improves antigen presentation to T cells
687
Targeting to sialoadhesin receptor improves antigen presentation to T cells
688
Targeting to sialoadhesin receptor improves antigen presentation to T cells
689
Targeting to sialoadhesin receptor improves antigen presentation to T cells
690
Targeting transforming growth factor-β signaling in liver metastasis of colon cancer
691
Targeting triple negative breast cancer: Is p53 the answer?
692
Targeting truncated APE1 in mitochondria enhances cell survival after oxidative stress
693
Targeting tumor angiogenesis with histone deacetylase inhibitors
694
Targeting Tumor Architecture to Favor Drug Penetration: A New Weapon to Combat Chemoresistance in Pancreatic Cancer?
695
Targeting tumor cell motility to prevent metastasis
696
Targeting tumor microenvironment as a treatment strategy for hepatocellular carcinoma
697
Targeting tumor microenvironment: Crossing tumor interstitial fluid by multifunctional nanomedicines
698
Targeting tumor microenvironment: The key role of immune system
699
Targeting tumors with peptides from natural sources
700
Targeting uPA/uPAR in prostate cancer
701
Targeting Urban Congestion: Equity and Second-Best Issues
702
Targeting urban malnutrition: a multi-city analysis of the spatial distribution of childhood nutritional status
703
Targeting utility customers to improve energy savings from conservation and efficiency programs
704
Targeting versus universalism: An evaluation of indirect effects of the Employment Guarantee Scheme in India
705
Targeting Viral ORF3a Protein: A New Approach to Mitigate COVID-19 Induced Immune Cell Apoptosis and Associated Respiratory Complications
706
Targeting voltage-gated Ca2+ channels
707
Targeting voltage-gated Ca2+ channels
708
Targeting voracious appetite of malaria-infected red-blood cell
709
Targeting Wide-Range Oncogenic Transformation via PU24FCl, a Specific Inhibitor of Tumor Hsp90 Original Research Article
710
Targeting α-Synuclein in Parkinsonʹs Disease Review Article
711
Targeting β2-microglobulin for induction of tumor apoptosis in human hematological malignancies
712
Target–ion-source system for RNB facility at KEK Tanashi Original Research Article
713
Target-making in the Nuclear Physics Department at the Australian National University
714
Target-making in the Nuclear Physics Department at the Australian National University
715
Target-mass corrections and the Bloom-Gilman duality of the nucleon structure function
716
Target-mass dependence of the break-up of halo nuclei
717
Targetome Analysis Revealed Involvement of MiR-126 in Neurotrophin Signaling Pathway: A Possible Role in Prevention of Glioma Development
718
Target-oriented multifunctional organocatalysis for enantioselective synthesis of bicyclo[3.3.1]nona-2,6-dien-9-ones. A formal asymmetric synthesis of huperzine A
719
Target-oriented obstacle analysis by PESTEL modeling of energy efficiency retrofit for existing residential buildings in Chinaʹs northern heating region
720
Target-oriented synthesis: miscellaneous synthetic routes to access 1,4-enediones through the coupling of 1,3-dicarbonyl compounds with multiform substrates
721
Target-plane deposition of diamond-like carbon in pulsed laser ablation of graphite
722
Target-projectile symmetry effects on fast light-particle emissions in heavy ion reactions
723
Target-Pursuing Scheduling and Routing Policies for Multiclass Queueing Networks
724
Targetry for cyclotron production of no-carrier-added cadmium-109 from natAg(p,n)109Cd reaction
725
Targets and ion sources for RIB generation at the Holifield Radioactive Ion Beam Facility
726
Targets and ion sources for RIB generation at the Holifield Radioactive Ion Beam Facility
727
Targets and methods for the detection of processed animal proteins in animal feedstuffs
728
Targets and results of the Brazilian Biodiesel Incentive Program – Has it reached the Promised Land?
729
Targets and Tactics of Play Fighting: Competitive versus Cooperative Styles of Play in Japanese and Tonkean Macaques
730
Targets and target wheel mechanism for APEX
731
Targets and target wheel mechanism for APEX
732
Targetsʹ Awareness of Expectations and Behavioral Confirmation in Ongoing Interactions
733
Targets emitting transition radiation for performing X-ray lithography by the tabletop synchrotron MIRRORCLE-20SX
734
Targets emitting transition radiation for performing X-ray lithography by the tabletop synchrotron MIRRORCLE-20SX
735
Targets for Anti-HIV1- Agents as Personalized HIV Therapy: A Review Study
736
Targets for bulk hydrogen analysis using thermal neutrons
737
Targets for bulk hydrogen analysis using thermal neutrons
738
Targets for cancer therapy in childhood sarcomas
739
Targets for indole-3-carbinol in cancer prevention
740
Targets for laser-driven opacity measurements
741
Targets for mitigation of Greenhouse gases : Implications from a long-term perspective
742
Targets for S3 at SPIRAL2
743
Targets for S3 at SPIRAL2
744
Targets for the APEX experiment at ATLAS
745
Targets for the electron–positron pair spectrometer HADES
746
Targets for the electron–positron pair spectrometer HADES
747
Targets now set by G8 countries to reduce “diseases of poverty”
748
Targets of discrimination: Effects of race on responses to weapons holders
749
Targets of Nitric Oxide in a Mouse Model of Liver Inflammation by Corynebacterium parvum
750
Targets of opportunity in two landscapes of financial globalization
751
Targets of RNA-directed DNA methylation
752
Targets of uranium, plutonium, and curium for heavy-element research
753
Targets of uranium, plutonium, and curium for heavy-element research
754
Targets on superhydrophobic surfaces for laser ablation ion sources
755
Targets on superhydrophobic surfaces for laser ablation ion sources
756
Targets used in the production of radioactive ion beams at the HRIBF
757
Targets used in the production of radioactive ion beams at the HRIBF
758
Targets, drivers and metrics in software process improvement: Results of a survey in a multinational organization
759
Target-shaped possibilistic clustering applied to local-model identification
760
Target-site insensitivity to some acaricides in a field population of Tetranychus urticae Koch (Acari: Tetranychidae) from Egypt
761
Target-site Preferences of Sleeping Beauty Transposons Original Research Article
762
Target-space duality in heterotic and type I effective Lagrangians Original Research Article
763
Target-specific control of lymphoid-specific protein tyrosine phosphatase (Lyp) activity Original Research Article
764
Target-specific delivery of peptide-based probes for PET imaging
765
Target-specific rib biopsy using the gamma probe
766
Target-specific Tc(CO)3-complexes for in vivo imaging
767
Target-superspace in 2d dilatonic supergravity
768
Target-synchronization of the distributed wireless sensor networks under the same sleeping–awaking method
769
Targetting voltage-gated calcium channels in cardiovascular therapy
770
TARGISOL: An ISOL-database on the web
771
TARGUM AND TRANSLATION: A NEW APPROACH TO A CLASSIC PROBLEM
772
Ta–Rh binary alloys as a potential diffusion barrier between Cu and Si: Stability and failure mechanism of the Ta–Rh amorphous structures Original Research Article
773
Tariff and quota equivalence in the presence of asymmetric information
774
Tariff and tax reform: Dynamic implications
775
Tariff bindings and bilateral cooperation on export cartels
776
Tariff concessions in production sourcing
777
Tariff design with varying degrees of commitment
778
Tariff endogeneity: Evidence from 19th century Europe
779
Tariff escalation and invasive species damages
780
Tariff games: Cooperation with random variation in political regimes
781
Tariff jumping DFI and export substitution: Japanese electronics firms in Europe
782
Tariff jumping foreign investment and capital taxation
783
Tariff Pass-through and Firm’s Productivity: A Case Study of Iran
784
Tariff policy for a monopolist in a signaling game
785
Tariff rate quotas: structural and stability impacts in growing markets
786
Tariff Reduction, Tax Replacement, and Implications for Income Distribution in China,
787
Tariff revenue competition in a free trade area
788
Tariff structure of Japanese electric power companies: An empirical analysis using DEA
789
Tariff structures and access substitution of mobile cellular for fixed line in South Africa
790
Tariff-based incentives for improving coal-power-plant efficiencies in India
791
Tariffication and the Canadian Chicken Industry in the Uruguay Round Agreement
792
Tariff-induced capital inflow and welfare in the presence of unemployment and informal sector
793
Tariffing in the new IP/ATM environment
794
Tariff-jumping antidumping duties
795
Tariff-quality equilibrium and its implications for telecommunications regulation
796
Tariff-Rate Quota Liberalization: The Case of World Price Uncertainty and Supply Management
797
Tariffs and exchange rate dynamics redux
798
Tariffs and Schumpeterian growth
799
Tariffs and subsidies in Zimbabweʹs reforming electricity industry: steering a utility through turbulent times
800
Tariffs and the Byrd amendment
801
Tariffs and the most favored nation clause
802
Tariffs in monopolistic competition models with leisure-consumption trade-off
803
Tariffs, licensing and market structure
804
Tariffs, quality reversals and exit in vertically differentiated industries
805
Tariffs, quotas and terms-of-trade: The case of New Zealand
806
Târih-i Selânikî As A Social History Guide
807
Tarihin İçinden Geçerek Tarihi İzlemek, İrdelemek: Uluslararası Bilim Düşünce ve Sanatta Cizre Sempozyumu
808
Tarihsel Bağlam ve İsrâiliyyâtın Rivayetlerin Oluşumundaki Etkisi –Nüzulü İsa ile Alâkalı Bir Rivayet Bağlamında–
809
Tarihten Notlar: Abbas Vesim Efendi (öl.1760)
810
Tarihten Notlar: Ord. Prof. Dr. Cemil Topuzlu (1866-1958)
811
TARIK BUĞRA’S LANGUAGE, ART AND LITERATURE OPINIONS FROM DÜŞMAN KAZANMAK SANATI
812
Tarmo: A Framework for Parallelized Bounded Model Checking
813
Tarnish protection of silver by octadecanethiol self-assembled monolayers prepared in aqueous micellar solution
814
Tarnish protection of silver jewels by plasmapolymer coatings
815
Tarnishing resistance of silver–palladium thin films
816
TARP: A traffic-aware restructuring protocol for Bluetooth radio networks
817
TARP: Ticket-based address resolution protocol
818
Tarsal morphology and attachment ability of the codling moth Cydia pomonella L. (Lepidoptera, Tortricidae) to smooth surfaces
819
Tarsal movements in flies during leg attachment and detachment on a smooth substrate
820
Tarsal Suspension Canthoplasty,
821
Tarsal taste neurons of Helicoverpa assulta (Guenée) respond to sugars and amino acids, suggesting a role in feeding and oviposition
822
Tarsal tunnel syndrome after total ankle replacement—a report of 3 cases
823
Tarsal tunnel syndrome caused by talocalcaneal coalition
824
Tarsal tunnel syndrome in patients with rheumatoid arthritis, electrophysiological and ultrasound study
825
tar-shaped oligo(p-phenylene)-functionalized truxenes as blue-light-emitting materials: synthesis and the structure–property relationship
826
Tarsier and ICMS: two approaches to framework development Original Research Article
827
Tarsier: a practical software framework for model development, testing and deployment
828
Tarski, truth and natural languages Original Research Article
829
Tarskian Set Constraints
830
Tarskiʹs conception of logic Original Research Article
831
Tarskiʹs definition and truth-makers Original Research Article
832
Tarskiʹs theory of definability: common themes in descriptive set theory, recursive function theory, classical pure logic, and finite-universe logic Original Research Article
833
Tart cherry anthocyanins inhibit tumor development in ApcMin mice and reduce proliferation of human colon cancer cells
834
Tartaglia’s ragioni: A maestro d’abaco’s mixed approach to the bombardier’s problem
835
Tartan Colour to sell for MD-Both & Wolstenholme
836
Tartarate precursors to CoxZn1−xGa2O4 spinel oxides
837
Tartaric acid assisted synthesis of Li2FeSiO4/C: Effect of carbon content on the electrochemical performance of Li2FeSiO4/C for lithium ion batteries
838
Tartaric acid production by ion exchange resin-filling electrometathesis and its process economics
839
Tartaric acid-assisted sol–gel synthesis of LiNi0.5Co0.5−xTixO2 (0 ⩽ x ⩽ 0.5) as cathode materials for lithium-ion batteries
840
Tartaric acid-assisted sol–gel synthesis of LiNi0.8Co0.2O2 and its electrochemical properties as a cathode material for lithium batteries
841
Tartaric acid–Ni supported catalysts obtained from hydrotalcite-like compounds: Effects of catalyst preparation variables on enantioselectivity Original Research Article
842
Tartary buckwheat improves cognition and memory function in an in vivo amyloid-β-induced Alzheimer model
843
Tartradiamide formation by thermolysis of tartaric acid with alkylamines
844
Tartrate dehydrogenase reductive decarboxylation: stereochemical generation of diastereotopically deuterated hydroxymethylenes
845
Tartrate Dehydrogenase, a New Member of the Family of Metal-Dependent Decarboxylating R-Hydroxyacid Dehydrogenases
846
Tartrate Dehydrogenase-Oxalate Complexes: Formation of a Stable Analog of a Reaction Intermediate Complex
847
Tartrate resistant acid phosphatase (TRACP 5b) as a resorption marker in patients with secondary hyperparathyroidism treated with cinacalcet
848
Tartrate-resistant acid phosphatase 5a and 5b contain distinct sugar moieties
849
Tartrazine Removal from Aqueous Solution by HDTMA-Br-Modified Colombian Bentonite
850
Tartuferiʹs retina
851
Tarwinia australis (Siphonaptera: Tarwiniidae) from the Lower Cretaceous Koonwarra fossil bed: Morphological revision and analysis of its evolutionary relationship
852
Tarzan as a cultural prism: Ideological Associations in Edgar Rice Burroughs’s Tarzan of the Apes
853
TASA: A New Task Scheduling Algorithm in Cloud Computing
854
Tasahul imam al-tirmidhi terhadap hukum hadith : Analisis pendapat ulama
855
Tasawuf in Different Derivations
856
TASC: Two-attribute-set clustering through decision tree construction
857
TaSe, a Taylor series-based fuzzy system model that combines interpretability and accuracy
858
Taser Research in Pigs Not Helpful
859
TASG: An Augmented Classification Method for Impersonal HAR
860
tashkent Uzbek health care—no longer back in the USSR
861
Ta–Si contacts to n-SiC for high temperatures devices
862
TASISpec—A highly efficient multi-coincidence spectrometer for nuclear structure investigations of the heaviest nuclei
863
TASISpec—A highly efficient multi-coincidence spectrometer for nuclear structure investigations of the heaviest nuclei
864
Task analysis for computer-aided design (CAD) at a keystroke level
865
Task analysis interview based on task ontology
866
Task analysis of human-in-the-loop tele-operated maintenance: What can be learned from JET?
867
Task analysis training of case managers to assist seriously mentally ill patients find roommates and housing
868
Task analysis, calculation and approximation: The work of Stuart K. Card, 2007 Bower Laureate in Computer & Cognitive Science for Human-Centered Computing
869
Task and socioemotional behaviors of physicians: a test of reciprocity and social interaction theories in analogue physician–patient encounters
870
Task and technology fit: a comparison of two technologies for synchronous and asynchronous group communication
871
Task assignment and transaction clustering heuristics for distributed systems
872
Task assignment in a heterogeneous server farm with switching delays and general energy-aware cost structure
873
Task automata: Schedulability, decidability and undecidability
874
Task aversiveness and procrastination: a multi-dimensional approach to task aversiveness across stages of personal projects
875
Task Classification Based Energy-Aware Consolidation in Clouds
876
Task cluster scheduling in a grid system
877
Task completion competency and project management performance: The influence of control and user contribution
878
Task complexity affects information seeking and use
879
Task Complexity and Grammatical Development in English as a Second Language
880
Task complexity and linguistic and discourse features of narrative writing performance
881
Task Complexity and the Speed and Efficiency of Elemental Information Processing: Another Look at the Nature of Intellectual Giftedness
882
Task Complexity Manipulation and Accuracy in Writing Performance
883
Task Complexity Manipulation and EFL learners’ interactions in the process of collaborative pre-planning
884
Task Complexity Manipulation and EFL learners’ interactions in the process of collaborative pre-planning
885
TASK COMPLEXITY, FOCUS ON FORM, AND SECOND LANGUAGE DEVELOPMENT
886
Task complexity, problem structure and information actions: Integrating studies on information seeking and retrieval
887
Task concentration training versus applied relaxation, in combination with cognitive therapy, for social phobia patients with fear of blushing, trembling, and sweating
888
Task Condition and EFL Learners’ Individual Differences: The Mediation of Tolerance of Ambiguity and Self-efficacy
889
Task Condition and L2 oral Performance: Investigating the Combined Effects of Online Planning and Immediacy
890
Task constraints and visual feature binding
891
Task coordination and aging: explorations of executive control processes in the task switching paradigm
892
Task decomposition and modular single-hidden-layer perceptron classifiers for multi-class learning problems
893
Task decomposition on abstract states, for planning under nondeterminism Original Research Article
894
Task demand effects on postural control in older adults
895
Task demands and human capabilities in door use
896
Task demands and knowledge influence how children learn to read words
897
Task dependence of Ia presynaptic inhibition in human wrist extensor muscles: a single motor unit study
898
Task dependency in back muscle fatigue – Correlations between two test methods
899
Task dependent cross-modal processing in early sensory cortices
900
Task Design Characteristics and EFL Learners’ Complexity, Accuracy and Fluency during Uncontrolled Pair Interactions: A Naturalistic Perspective
901
Task design, psycho-social work climate and upper extremity pain disorders - effects of an organisational redesign on manual repetitive assembly jobs
902
Task Development for an Online English Technical Vocabulary Self-Learning System for Engineering Students
903
Task Difficulty and Its Components: Are They Alike or Different across Different Macro-genres?
904
Task difficulty in a simultaneous face matching task modulates activity in face fusiform area
905
Task difficulty in speaking tests
906
Task difficulty, incentive effects, and the selection of high-variance strategies: an experimental examination of tournament behavior
907
Task difficulty, task variability and satisfaction with management support systems
908
Task difficulty, task variability and satisfaction with management support systems
909
Task Effectiveness Predictors: Technique Feature Analysis versus Involvement Load Hypothesis
910
Task effects in masked cross-script translation and phonological priming
911
Task effects reveal cognitive flexibility responding to frequency and predictability: Evidence from eye movements in reading and proofreading
912
Task effects, performance levels, features, configurations, and holistic face processing: A reply to Rossion
913
Task experience and validity in perceptual mapping A comparison of two consumer-adaptive techniques
914
Task force #1—identification of coronary heart disease risk: is there a detection gap?
915
Task Force #1—magnitude of the prevention problem: opportunities and challenges
916
Task Force #2—the cost of prevention: can we afford it? Can we afford not to do it?
917
Task force #2—what is the pathologic basis for new atherosclerosis imaging techniques?
918
Task Force #3—getting results: who, where, and how?
919
Task force #3—what is the spectrum of current and emerging techniques for the noninvasive measurement of atherosclerosis?
920
Task Force #4—adherence issues and behavior changes: achieving a long-term solution
921
Task force #4—how do we select patients for atherosclerosis imaging?
922
Task force #5—is atherosclerosis imaging cost effective?
923
Task Force #5—the role of cardiovascular specialists as leaders in prevention: from training to champion
924
Task force 1. Pathogenesis of coronary disease: The biologic role of risk factors
925
Task Force 1: General Experiences and Training Review Article
926
Task Force 1: Preparticipation screening and diagnosis of cardiovascular disease in athletes Review Article
927
Task Force 1: The ACCF and AHA codes of conduct in human subjects research Review Article
928
Task Force 1: the changing profile of congenital heart disease in adult life
929
Task force 1: Training in clinical cardiology
930
Task Force 1: Training in Clinical Cardiology Review Article
931
Task Force 10: Automated external defibrillators Review Article
932
Task force 10: Training in preventive cardiovascular medicine
933
Task Force 10: Training in Preventive Cardiovascular Medicine Review Article
934
Task Force 11: Commotio cordis Review Article
935
Task Force 11: Training in Vascular Medicine and Peripheral Vascular Catheter-Based Interventions: Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society for Vascular Medicine Review Article
936
Task Force 12: Legal aspects of the 36th Bethesda Conference recommendations Review Article
937
Task Force 12: Training in Advanced Cardiovascular Imaging (Cardiovascular Magnetic Resonance [CMR]): Endorsed by the Society for Cardiovascular Magnetic Resonance Review Article
938
Task Force 12: Training in Advanced Cardiovascular Imaging (Cardiovascular Magnetic Resonance [CMR]): Endorsed by the Society for Cardiovascular Magnetic Resonance Review Article
939
Task Force 12: Training in Advanced Cardiovascular Imaging (Computed Tomography): Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Atherosclerosis Imaging and Prevention, and Soci
940
Task Force 13: Training in Advanced Cardiovascular Imaging (Computed Tomography): Endorsed by the American Society of Nuclear Cardiology, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, and Soci
941
Task force 2. Clinical epidemiology: The conceptual basis for interpreting risk factors
942
Task Force 2: Congenital heart disease Review Article
943
Task force 2: Investigator participation in clinical research Review Article
944
Task Force 2: Pediatric Training Guidelines for Noninvasive Cardiac Imaging: Endorsed by the American Society of Echocardiography and the Society of Pediatric Echocardiography Review Article
945
Task Force 2: special health care needs of adults with congenital heart disease
946
Task force 2: Training in electrocardiography, ambulatory electrocardiography and exercise testing
947
Task Force 2: Training in Electrocardiography, Ambulatory Electrocardiography, and Exercise Testing Review Article
948
Task force 3. Spectrum of risk factors for coronary heart disease
949
Task force 3: Disclosure of relationships with commercial interests: Policy for educational activities and publications Review Article
950
Task Force 3: Training Guidelines for Pediatric Cardiac Catheterization and Interventional Cardiology: Endorsed by the Society for Cardiovascular Angiography and Interventions Review Article
951
Task force 3: Training in cardiac catheterization and interventional cardiology
952
Task Force 3: Training in Diagnostic and Interventional Cardiac Catheterization: Endorsed by the Society for Cardiovascular Angiography and Interventions Review Article
953
Task Force 3: Valvular heart disease Review Article
954
Task Force 3: workforce description and educational requirements for the care of adults with congenital heart disease
955
Task force 4. Efficacy of risk factor management
956
Task force 4: Appropriate clinical care and issues of “self-referral” Review Article
957
Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome Review Article
958
Task Force 4: organization of delivery systems for adults with congenital heart disease
959
Task Force 4: Recommendations for Training Guidelines in Pediatric Cardiac Electrophysiology: Endorsed by the Heart Rhythm Society Review Article
960
Task force 4: Training in echocardiography
961
Task Force 4: Training in Echocardiography: Endorsed by the American Society of Echocardiography Review Article
962
Task force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management
963
Task Force 5: adults with congenital heart disease: access to care
964
Task force 5: Expert testimony and opinions Review Article
965
Task Force 5: Requirements for Pediatric Cardiac Critical Care Review Article
966
Task Force 5: Systemic hypertension Review Article
967
Task force 5: Training in nuclear cardiology
968
Task Force 5: Training in Nuclear Cardiology: Endorsed by the American Society of Nuclear Cardiology Review Article
969
Task Force 5: Training in Nuclear Cardiology: Endorsed by the American Society of Nuclear Cardiology Review Article
970
Task force 6. Cost effectiveness of assessment and management of risk factors
971
Task force 6: Code of conduct for staff and volunteer leadership Review Article
972
Task Force 6: Coronary artery disease Review Article
973
Task force 6: Training in specialized electrophysiology, cardiac pacing and arrhythmi management
974
Task Force 6: Training in Specialized Electrophysiology, Cardiac Pacing, and Arrhythmia Management: Endorsed by the Heart Rhythm Society Review Article
975
Task Force 6: Training in Specialized Electrophysiology, Cardiac Pacing, and Arrhythmia Management: Endorsed by the Heart Rhythm Society Review Article
976
Task Force 6: Training in Transition of Adolescent Care and Care of the Adult With Congenital Heart Disease Review Article
977
Task force 7. Evaluation and management of risk factors for the individual patient (case management)
978
Task Force 7: Arrhythmias Review Article
979
Task Force 7: Training Guidelines for Research in Pediatric Cardiology Review Article
980
Task force 7: Training in cardiovascular research
981
Task Force 7: Training in Cardiovascular Research Review Article
982
Task force 8. Organization of preventive cardiology service
983
Task Force 8: Classification of sports Review Article
984
Task force 8: Training in heart failure and transplantation
985
Task Force 8: Training in Heart Failure: Endorsed by the Heart Failure Society of America Review Article
986
Task Force 9: Drugs and performance-enhancing substances Review Article
987
Task force 9: Training in the care of adult patients with congenital heart disease
988
Task Force 9: Training in the Care of Adult Patients With Congenital Heart Disease Review Article
989
Task Force I: Direct Cardiovascular Implications of Emerging Infectious Diseases and Biological Terrorism Threats Review Article
990
Task Force II: Indirect and Secondary Cardiovascular Effects of Biological Terrorism Agents and Diseases Review Article
991
Task Force III: Prevention and Control of Cardiovascular Complications of Emerging Infectious Diseases and Potential Biological Terrorism Agents and Diseases Review Article
992
Task Force IV: Cardiovascular Effects of Emerging Infectious Diseases and Biological Terrorism Threats: Basic, Clinical, and Population Science Research and Training Needs Review Article
993
Task Force of the European Federation of Medical Informatics Journals: Background, Rationale and Purpose
994
TASK FORCE ON ALZHEIMER’S DISEASE TRIAL METHODOLOGY: RECRUITMENT AND RETENTION, DATA MANAGEMENT AND ANALYSIS. THE USE OF IMAGING IN RECRUITMENT: MAINTENANCE AND METHODOLOGICAL ISSUES IN ALZHEIMERʹS TRIALS
995
Task gender orientation perceptions by novice designers: implications for engineering design research, teaching and practice
996
Task goals and change in dynamical degrees of freedom with motor learning.
997
Task Implementation and EFL Learners’ Attention to Form: Examining the Effects of Pre-Task Planning and Post-Task transcription
998
Task Influences on Students’ Collaboration in Mathematics Teaching
999
Task instructions and implicit theory of mind
1000
Task instructions modulate neural responses to fearful facial expressions
